Equillium Consolidated Income from 2010 to 2024

EQ Stock  USD 1.77  0.08  4.32%   
Check Equillium financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Equillium main balance sheet or income statement drivers, such as Interest Income of 2.1 M, Interest Expense of 748.9 K or Selling General Administrative of 10.3 M, as well as many exotic indicators such as Price To Sales Ratio of 0.66, Dividend Yield of 0.22 or PTB Ratio of 1.53. Equillium financial statements analysis is a perfect complement when working with Equillium Valuation or Volatility modules.
  
This module can also supplement Equillium's financial leverage analysis and stock options assessment as well as various Equillium Technical models . Check out the analysis of Equillium Correlation against competitors.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.

About Equillium Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Equillium income statement, its balance sheet, and the statement of cash flows. Equillium investors use historical funamental indicators, such as Equillium's Consolidated Income, to determine how well the company is positioned to perform in the future. Although Equillium investors may use each financial statement separately, they are all related. The changes in Equillium's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Equillium's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Equillium Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Equillium. Please read more on our technical analysis and fundamental analysis pages.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. Equillium operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving together with Equillium Stock

  0.74ERAS Erasca Inc Financial Report 20th of May 2024 PairCorr

Moving against Equillium Stock

  0.83AMGN Amgen Inc Financial Report 25th of April 2024 PairCorr
  0.74BIIB Biogen Inc Financial Report 23rd of April 2024 PairCorr
  0.66ABVC ABVC BiopharmaPairCorr
  0.53VRTX Vertex Pharmaceuticals Financial Report 6th of May 2024 PairCorr
The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out the analysis of Equillium Correlation against competitors.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.38)
Revenue Per Share
1.039
Quarterly Revenue Growth
(0.42)
Return On Assets
(0.14)
Return On Equity
(0.49)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.